Acumen Pharmaceuticals, Inc. (ABOS) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Individuals Enrolled in Altitude-AD Early Alzheimer's Disease | 542.00 | FY2026-Q1 |
Back to ABOS overview · ABOS earnings · ABOS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.